MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA and others have been doing to support implementation of maternal vaccines
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
As part of a listening and gathering process for the project ‘Improving Trustworthiness in Global Health’, Conrad Keating (Adjunct Professor and writer-in-residence at the School of Medicine, University College Dublin) ...
From 18–21 November 2025, the AMR Knowledge Hub and Community of Practice of The Global Health Network convened over 400 healthcare professionals, researchers, and policymakers from more than 50 countries ...
Góc nhìn tâm lý dành cho nhân viên y tế.Trong môi trường y tế, không chỉ có những ca trực kéo dài hay áp lực chuyên môn nặng nề. Cómột ...
Geneva, 25 July 2025 – The Board of Gavi, the Vaccine Alliance this week endorsed a series of adjustments to bring Gavi’s strategy for its next five-year period (2026-2030) in line with available resources while it continues to engage with ... Read more
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more
